Trial Profile
A Study to Evaluate the Efficacy and Safety of Sorafenib monotherapy and Sorafenib plus Interferon Combination Therapy in Patients with Advanced Hepatocellular Carcinoma (HCC)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Interferon (Primary) ; Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Dec 2015 New trial record